Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia

Overview of attention for article published in Journal of Blood Medicine, May 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#44 of 292)
Good Attention Score compared to outputs of the same age (76th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 47 Mendeley

Summary News Dimensions citations

So far, Dimensions has found 19 publications that cite this research output.

19

The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.

Progress in the Treatment of Eltrombopag for Adult Primary Immune Thrombocytopenia

Article in Advances in Clinical Medicine (January 2024)

Purification and Activity Evaluation of a Novel Thrombopoietin Mimetic Peptide

Article in Journal of Pharmaceutical Sciences (November 2023)

Fostamatinib or Thrombopoietin for the Treatment of Chronic Immune Thrombocytopenia in Adult Patients: A Real-World Assessment of Safety, Effectiveness and Cost

Article in Acta Haematologica (September 2023)